Guardian Pharmacy Services (NYSE:GRDN) Posts Quarterly Earnings Results, Beats Expectations By $0.10 EPS

Guardian Pharmacy Services (NYSE:GRDN) released its earnings results on Wednesday. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.27 by $0.10, FiscalAI reports. The business had revenue of $397.62 million during the quarter, compared to analysts’ expectations of $390.04 million. Guardian Pharmacy Services had a return on equity of 30.29% and a net margin of 2.90%.

Guardian Pharmacy Services Stock Performance

Guardian Pharmacy Services stock traded up $0.13 during mid-day trading on Wednesday, reaching $33.78. The stock had a trading volume of 601,395 shares, compared to its average volume of 238,147. The firm has a market capitalization of $2.14 billion, a PE ratio of 53.62 and a beta of 0.86. Guardian Pharmacy Services has a fifty-two week low of $18.50 and a fifty-two week high of $37.43. The stock’s 50-day simple moving average is $31.73 and its 200-day simple moving average is $29.29.

Hedge Funds Weigh In On Guardian Pharmacy Services

A number of large investors have recently modified their holdings of GRDN. Ameritas Investment Partners Inc. increased its stake in Guardian Pharmacy Services by 26.5% during the 3rd quarter. Ameritas Investment Partners Inc. now owns 1,647 shares of the company’s stock valued at $43,000 after purchasing an additional 345 shares in the last quarter. California State Teachers Retirement System raised its holdings in Guardian Pharmacy Services by 3.4% during the fourth quarter. California State Teachers Retirement System now owns 17,983 shares of the company’s stock worth $541,000 after buying an additional 593 shares during the last quarter. Police & Firemen s Retirement System of New Jersey lifted its stake in shares of Guardian Pharmacy Services by 20.4% in the fourth quarter. Police & Firemen s Retirement System of New Jersey now owns 6,070 shares of the company’s stock valued at $183,000 after buying an additional 1,028 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in shares of Guardian Pharmacy Services by 13.4% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 11,885 shares of the company’s stock valued at $358,000 after buying an additional 1,409 shares during the last quarter. Finally, JPMorgan Chase & Co. increased its position in shares of Guardian Pharmacy Services by 31.1% during the third quarter. JPMorgan Chase & Co. now owns 7,899 shares of the company’s stock worth $207,000 after acquiring an additional 1,872 shares in the last quarter.

Analysts Set New Price Targets

A number of equities analysts have issued reports on the company. Stephens increased their price target on Guardian Pharmacy Services from $35.00 to $36.00 and gave the stock an “overweight” rating in a report on Wednesday, January 14th. Weiss Ratings reiterated a “hold (c+)” rating on shares of Guardian Pharmacy Services in a research report on Monday, December 29th. Wall Street Zen raised shares of Guardian Pharmacy Services from a “buy” rating to a “strong-buy” rating in a research note on Monday, November 17th. Finally, Truist Financial raised their price target on shares of Guardian Pharmacy Services from $30.00 to $34.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company’s stock. According to data from MarketBeat, Guardian Pharmacy Services has an average rating of “Moderate Buy” and an average price target of $32.00.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.